|
|
|
|
||
TLR-9 dataTwo other TLR-9 companies presented their Data and they all look the similar ORR but only difference is that IDRA is way ahead of the game with Phase-3 data expected in next three months while others has to wait for for another 3+ years. checkmate: https://ir.checkmatepharma.com/news-releases/news-release-details/checkmate-pharmaceuticals-presents-updated-clinical-data-cmp-001 Exicur: https://investors.exicuretx.com/news/news-details/2020/Exicure-Presents-Positive-Clinical-Data-with-Cavrotolimod-at-The-Society-for-Immunotherapy-of-Cancer-SITC-35th-Anniversary-Annual-Meeting/default.aspx Feel free to leave your comments w.r.t data comparison with IDRA. |
return to message board, top of board |